|
| 37977167 | The future of cancer care in the UK-time for a radical and sustainable National Cancer Plan. | Lancet Oncol | 2024 |
| 36082449 | Global colorectal cancer research, 2007-2021: Outputs and funding. | Int J Cancer | 2023 |
| 37839622 | Health diplomacy in action: The cancer legacy of the Good Friday Agreement. | J Cancer Policy | 2023 |
| 37606853 | The impact of the COVID-19 pandemic on community prescription of opioid and antineuropathic analgesics for cancer patients in Wales, UK. | Support Care Cancer | 2023 |
| 37813780 | Gender inequity in cancer research leadership in Europe: Time to act. | Eur J Cancer | 2023 |
| 37182343 | Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients. | Eur J Cancer | 2023 |
| 37408046 | Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach. | J Pharm Policy Pract | 2023 |
| 37142369 | The rise of immuno-oncology in China: a challenge to western dominance? | Lancet Oncol | 2023 |
| 36725142 | Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission. | Lancet Oncol | 2023 |
| 36720858 | Author Correction: Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features. | Nat Commun | 2023 |
| 36812845 | Far-reaching impact of the Russian invasion of Ukraine on global cancer research. | Eur J Cancer | 2023 |
| 36841473 | Impact of the COVID-19 pandemic on cancer care in Ireland - Perspectives from a COVID-19 and Cancer Working Group. | J Cancer Policy | 2023 |
| 36869930 | Cost consequences of unscheduled emergency admissions in cancer patients in the last year of life. | Support Care Cancer | 2023 |
| 36707908 | A comparison of international modelling methods to evaluate health economics of colorectal cancer screening: a systematic review protocol. | Syst Rev | 2023 |
| 36938773 | Engaging European society at the forefront of cancer research and care: How discussions at the 5<sup>th</sup> Gago Conference on European Science policy led to the Heidelberg Manifesto | Mol Oncol | 2023 |
| 34389490 | Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems. | Semin Cancer Biol | 2022 |
| 35477539 | Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer. | Gut | 2022 |
| 35537476 | Indirect effects of the pandemic: highlighting the need for data-driven policy and preparedness. | J R Soc Med | 2022 |
| 35501391 | Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system. | Br J Cancer | 2022 |
| 35792866 | Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data. | Clin Cancer Res | 2022 |
| 35718327 | Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer. | J Cancer Policy | 2022 |
| 35361119 | classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes. | BMC Bioinformatics | 2022 |
| 35358453 | Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement. | Lancet Oncol | 2022 |
| 36477656 | Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features. | Nat Commun | 2022 |
| 36130783 | Don't make cancer survivors pay twice-the right for them to be "forgotten" should be law everywhere. | BMJ | 2022 |
| 36328024 | Exploring the link between cancer policies and cancer survival: a comparison of International Cancer Benchmarking Partnership countries. | Lancet Oncol | 2022 |
| 35115384 | Data must underpin our response to the covid-19 pandemic's disastrous impact on cancer. | BMJ | 2022 |
| 35112706 | Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data. | Dis Model Mech | 2022 |
| 34732839 | Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populations. | Mod Pathol | 2022 |
| 34754079 | An atlas of inter- and intra-tumor heterogeneity of apoptosis competency in colorectal cancer tissue at single-cell resolution. | Cell Death Differ | 2022 |
| 32855306 | Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study. | Gut | 2021 |
| 35559911 | The European Code of Cancer Practice. | J Cancer Policy | 2021 |
| 33713606 | Predicting endoscopic activity recovery in England after COVID-19: a national analysis. | Lancet Gastroenterol Hepatol | 2021 |
| 33928242 | Evolutionary genetic algorithm identifies <i>IL2RB</i> as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer. | NAR Genom Bioinform | 2021 |
| 34377737 | Evidence generation and reproducibility in cell and gene therapy research: A call to action. | Mol Ther Methods Clin Dev | 2021 |
| 34389694 | Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer. | Mol Cancer Ther | 2021 |
| 34053182 | Challenges and solutions to embed cancer survivorship research and innovation within the EU Cancer Mission. | Mol Oncol | 2021 |
| 34110679 | Cost-effectiveness of precision diagnostic testing for precision medicine approaches against non-small-cell lung cancer: A systematic review. | Mol Oncol | 2021 |
| 34329626 | The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study. | Lancet Gastroenterol Hepatol | 2021 |
| 33028592 | In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer. | Clin Cancer Res | 2021 |
| 32114365 | The 'Good Friday Agreement' and cancer research on the island of Ireland: Evidence for the impact of a tripartite cancer research partnership. | Eur J Cancer | 2020 |
| 33855271 | The future of genomics in Ireland - focus on genomics for health. | HRB Open Res | 2020 |
| 33203640 | Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. | BMJ Open | 2020 |
| 32775335 | Propelling Health Care into the Twenties. | Biomed Hub | 2020 |
| 32684627 | Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia. | Br J Cancer | 2020 |
| 32702311 | Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. | Lancet Oncol | 2020 |
| 32672449 | Synthesis, Characterization, and Biological Profiling of Ruthenium(II)-Based 4-Nitro- and 4-Amino-1,8-naphthalimide Conjugates. | Inorg Chem | 2020 |
| 32339197 | The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration. | PLoS One | 2020 |
| 32246132 | A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer. | Nat Genet | 2020 |
| 32335477 | Cancer and coronavirus disease 2019; how do we manage cancer optimally through a public health crisis? | Eur J Cancer | 2020 |